TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-β in cervical carcinoma cells

Oncogene

Volumn 24, Issue 15, 2005, Pages 2536-2546

  Vannucchi, Serena ^a   Chiantore, Maria V ^a   Fiorucci, Gianna ^a,b   Percario, Zulema A ^c   Leone, Stefano ^c   Affabris, Elisabetta ^c   Romeo, Giovanna ^a,b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CNR   (Italy)

^c ROMA TRE UNIVERSITY   (Italy)

Author keywords

Apoptosis; Cell cycle; IFN ; SCC; TRAIL

Indexed keywords

BETA1A INTERFERON; CASPASE; DEATH RECEPTOR 5; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN E6; PROTEIN P53; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE S PHASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS; UTERINE CERVIX CARCINOMA; WART VIRUS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA; CASPASES; FEMALE; GENE EXPRESSION PROFILING; GENES, P53; HUMANS; INTERFERON-BETA; MEMBRANE GLYCOPROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; RNA, MESSENGER; S PHASE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS;

EID: 17844379782     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208403     Document Type: Article

References (41)

1. Armitage RJ. (1994). Curr. Opin. Immunol., 6, 407-413.
2. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH. (1999). J. Clin. Invest., 104, 155-162.
3. Baetu TM and Hiscott J. (2002). Cytokine Growth Factor Rev., 13, 199-207.
4. Baetu TM, Kwon H, Sharma S, Grandvaux N and Hiscott J. (2001). Immunology, 167, 3164-3173.
5. Blandino G, Levine AJ and Oren M. (1999). Oncogene, 18, 477-485.
6. Borden EC, Lindner D, Dreicer R, Hussein M and Peereboom D. (2000). Semin. Cancer Biol., 10, 125-144.
7. Chawla-Sarkar M, Leaman DW and Borden EC. (2001). Cancer Res., 7, 1821-1831.
8. Chawla-Sarkar M, Leaman DW, Jacobs BS and Borden EC. (2002). J. Immunol., 169, 847-855.
9. Chen C, Edelstein LC and Gelinas C. (2000). Mol. Cell. Biol., 20, 2687-2695.
10. Chen Q, Gong B, Mahmoud-Ahmed AS, Zhou A, His ED, Hussein M and Almasan A. (2001). Blood, 98, 2183-2192.
11. Choi EA, Lei H, Maron DJ, Wilson JM, Barsoum J, Fraker DL, El-Deiry WS and Spitz FR. (2003). Cancer Res., 63, 5299-5307.
12. El-Deiry WS. (2001). Cell Death Differ., 8, 1066-1075.
13. Fanger NA, Maliszewski CR, Schooley K and Griffith TS. (1999). J. Exp. Med., 190, 1155-1164.
14. Fiorucci G, Vannucchi S, Chiantore MV, Percario ZA, Affabris E and Romeo G. (2005). Curr. Pharm. Des., 10 (in press).
15. Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K, Pandolfi PP, Will H, Schneider C and Del Sal G. (2000). EMBO J., 19, 6185-6195.
16. Ghosh SK, Wood C, Boise LH, Mian AM, Deyev VV, Feuer G, Toomey NL, Shank NC, Cabral L, Barber GN and Harrington Jr WJ. (2003). Blood, 101, 2321-2327.
17. Giandomenico V, Vaccari G, Fiorucci G, Percario Z, Matarrese P, Malorni W, Romeo G and Affabris E. (1998). Eur. Cytokine Network, 9, 613-631.
18. Gibson SB, Oyer R, Spalding AC, Anderson SM and Johnson GL. (2000). Mol. Cell. Biol., 20, 205-212.
19. Gong B and Almasan A. (2000). Biochem. Biophys. Res. Commun., 278, 747-752.
20. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P and Korsmeyer SJ. (1999). J. Biol. Chem., 274, 1156-1163.
21. Hu WH, Johnson H and Shu HB. (1999). J. Biol. Chem., 274, 30603-30610.
22. Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K and Yagita H. (1999). J. Exp. Med., 189, 1451-1460.
23. Meng RD and El-Deiry WS. (2001). Exp. Cell Res., 262, 154-169.
24. Muhlenbeck F, Schneider P, Bodmer JL, Schwenzer R, Hauser A, Schubert G, Scheurich P, Moosmayer D, Tschopp J and Wajant H. (2000). J. Biol. Chem., 275, 32208-32213.
25. Oshima K, Yanase N, Ibukiyama C, Yamashina A, Kayagaki N, Yagita H and Mizuguchi J. (2001). Cytokine, 14, 193-201.
26. Percario ZA, Giandomenico V, Fiorucci G, Chiantore MV, Vannucchi S, Hiscott J, Affabris E and Romeo G. (1999). Cell Growth Differ., 10, 263-270.
27. Pucci B, Kasten M and Giordano A. (2000). Neoplasia, 2, 291-299.
28. Sato K, Hida S, Takayanagi H, Yokochi T, Kayagaki N, Takeda K, Yagita H, Okumura K, Tanaka N, Taniguchi T and Ogasawara K. (2001). Eur. J. Immunol., 31, 3138-3146.
29. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME. (1998). EMBO J., 17, 1675-1687.
30. Sedger LM, Shows DM, Blanton RA, Peschon JJ, Goodwin RG, Cosman D and Wiley SR. (1999). J. Immunol., 163, 920-926.
31. Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fornace Jr AJ and El-Deiry WS. (1998). Cancer Res., 58, 1593-1598.
32. Shetty S, Gladden JB, Henson ES, Hu X, Villanueva J, Haney N and Gibson SB. (2002). Apoptosis, 7, 413-420.
33. Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N and Eguchi K. (2003). Oncogene, 22, 1653-1662.
34. Shin E-C, Seong YR, Kim CH, Kim H, Ahn YS, Kim K, Kim SJ, Hong S-S and Park JH. (2002). Exp. Mol. Med., 34, 114-122.
35. Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, Zhou Q, Ellerby HM, Ellerby LM, Bredesen D, Green DR, Reed JC, Froelich CJ and Salvesen GS. (1998). J. Biol. Chem., 273, 27084-27090.
36. Toomey NL, Deyev VV, Wood C, Boise LH, Scott D, Liu LH, Cabral L, Podack ER, Barber GN and Harrington Jr WJ. (2001). Oncogene, 20, 7029-7040.
37. Vannucchi S, Precario ZA, Chiantore MV, Matarrese P, Chelbi-Alix MK, Fagioli M, Pelicci PG, Malori W, Fiorucci G, Romeo G and Affabris E. (2000). Oncogene, 9, 5041-5053.
38. Wang CY, Mayo MW, Korneluk R, Goeddel DV and Baldwin Jr AS. (1998). Science, 281, 1680-1683.
39. Wang Q, Ji Y, Wang X and Evers BM. (2000). Biochem. Biophys. Res. Commun., 276, 466-471.
40. Wilson CA and Browning JL. (2002). Cell Death Differ., 9, 1321-1333.
41. Younes A and Kadin ME. (2003). J. Clin. Oncol, 21, 3526-3534.